About AbCheck
AbCheck is a company based in Plzen (Czechia) founded in 2009 was acquired by Ampersand in January 2024. AbCheck operates in a competitive market with competitors including Adimab, Aphios, CDI Labs, QuaDRAD and OmniAb, among others.
- Headquarter Plzen, Czechia
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abcheck S.R.O.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of AbCheck
Unlock access to complete
Unlock access to complete
Funding Insights of AbCheck
Detailed funding history for AbCheck
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AbCheck
AbCheck has secured backing from 1 investor. Prominent investors backing the company include Ampersand.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Programmable medicines are developed to target and treat multiple diseases.
|
Locked | Locked | Locked |
Investor details for AbCheck
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AbCheck
Investment portfolio details for AbCheck
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AbCheck
Detailed financials for AbCheck
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Abcheck Comparisons
Peer comparison for AbCheck
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AbCheck
AbCheck operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adimab, Aphios, CDI Labs, QuaDRAD and OmniAb, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibodies are discovered and optimized for autoimmune and infectious diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for cancer and infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Autoantibody detection and profiling products and services are provided.
|
|
| Locked | Locked | Locked |
Antibody drug discovery platform
|
|
| Locked | Locked | Locked |
Transgenic animal platforms are developed for human therapeutic antibody production.
|
Detailed competitors of AbCheck
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Abcheck
Complete news archive for AbCheck
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AbCheck
AbCheck was founded in 2009.
AbCheck is headquartered in Plzen, Czechia. It is registered at Plzen, Plzen Region, Czechia.
AbCheck is a spin-out of Affimeds technology platform (part of Affimed). They are involved in the development of human therapeutic antibodies for treating cancer. The company offers proprietary platforms including proprietary libraries, rabbit mass humanization, AbSieve (antibody screeningselection tool), and AbAccel (antibody optimization in a single process).
AbCheck has 1 investor. Key investors include Ampersand.